Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Bladder Cancer

Free Subscription 08.04.2019 1 Actas Urol Esp 1 BMJ Case Rep 3 Can J Urol 1 Cancer Control 2 Cancer Cytopathol 1 Cancer Med 1 Ceylon Med J 1 Crit Rev Oncol Hematol 1 Curr Opin Urol 1 Curr Probl Cancer 1 Eur Urol Oncol 2 Front Oncol 1 Future Oncol 2 Histopathology 1 In Vivo 1 Indian J Cancer 1 Int J Cancer 2 Int J Oncol 2 Int Urol Nephrol 1 J BUON 1 J Cell Mol Med 2 J Cell Physiol 1 J Exp Clin Cancer Res 1 J Pathol 1 J Urol 1 Korean J Radiol 1 Mod Pathol 1 Mol Cancer Ther 1 Mol Immunol 1 Mol Ther 1 Oncologist 1 Scand J Urol 1 Toxicol Appl Pharmacol 1 World J Urol 1 Zhonghua Wai Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Actas Urol Esp

1. SUBIRA-RIOS D, Herranz-Amo F, Moralejo-Garate M, Cano-Velasco J, et al
   Post-surgical complications in patients with bladder cancer treated with cystectomy: Differences between open and laparoscopic approach.
   Actas Urol Esp. 2019 Mar 29. pii: S0210-4806(19)30006.
   PubMed     Text format     Abstract available
   
   

   
   BMJ Case Rep

2. GARG G, Sharma A, Sharma A, Sankhwar S, et al
   Metastatic adenocarcinoma of bladder presenting with skin and visceral metastasis.
   BMJ Case Rep. 2018;11.
   PubMed     Text format     Abstract available
   
   

   
   Can J Urol

3. MORGANSTERN BA, Scaccia S, Wu W, Williamson AK, et al
   Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: a novel genetic case report.
   Can J Urol. 2018;25:9357-9359.
   PubMed     Text format     Abstract available
   
   
4. LEE AJ, Yabes JG, Hale N, Hrebinko RL, et al
   The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.
   Can J Urol. 2018;25:9255-9261.
   PubMed     Text format     Abstract available
   
   
5. MCARDLE BJ, Vidal P, Psutka SP, Hollowell CMP, et al
   T4 urothelial carcinoma in undiagnosed closed bladder exstrophy in a post-menopausal female.
   Can J Urol. 2018;25:9214-9216.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Control

6. MINATO A, Noguchi H, Tomisaki I, Fukuda A, et al
   Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
   Cancer Control. 2018;25:1073274818800269.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Cytopathol

7. PIERCONTI F, Rossi ED, Straccia P, Fadda G, et al
   The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
   Cancer Cytopathol. 2018;126:200-206.
   PubMed     Text format     Abstract available
   
   
8. WANG Y, Auger M, Kanber Y, Caglar D, et al
   Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
   Cancer Cytopathol. 2018;126:207-214.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Med

9. HAGGSTROM C, Garmo H, de Luna X, Van Hemelrijck M, et al
   Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.
   Cancer Med. 2019 Apr 1. doi: 10.1002/cam4.2126.
   PubMed     Text format     Abstract available
   
   

   
   Ceylon Med J

10. JAYARAJAH U, Fernando MH, Herath KB, Kuruppu SN, et al
    Clinico-pathological characteristics and outcome of upper urinary tract urothelial carcinoma presenting to a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:129-132.
    PubMed     Text format     Abstract available
    
    

    
    Crit Rev Oncol Hematol

11. MAIA MC, Hansen A, Alves C, Salah S, et al
    Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review.
    Crit Rev Oncol Hematol. 2019;135:76-84.
    PubMed     Text format     Abstract available
    
    

    
    Curr Opin Urol

12. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    PubMed     Text format     Abstract available
    
    

    
    Curr Probl Cancer

13. ZEKRI AN, Khaled HM, Mohammed MB, Diab FM, et al
    Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study.
    Curr Probl Cancer. 2019 Mar 26. pii: S0147-0272(18)30459.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol Oncol

14. BEULENS AJW, van der Toorn PP, de Wildt MJ, Scheepens WA, et al
    High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers.
    Eur Urol Oncol. 2019;2:39-46.
    PubMed     Text format     Abstract available
    
    

    
    Front Oncol

15. BODGI L, Bahmad HF, Araji T, Al Choboq J, et al
    Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach.
    Front Oncol. 2019;9:153.
    PubMed     Text format     Abstract available
    
    
16. OH JJ, Byun SS, Jeong CW, Kwak C, et al
    Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.
    Front Oncol. 2019;9:158.
    PubMed     Text format     Abstract available
    
    

    
    Future Oncol

17. FLANNERY K, Boyd M, Black-Shinn J, Robert N, et al
    Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
    Future Oncol. 2019 Apr 3. doi: 10.2217/fon-2018-0654.
    PubMed     Text format     Abstract available
    
    

    
    Histopathology

18. MCKENNEY JK
    Precursor lesions of the urinary bladder.
    Histopathology. 2019;74:68-76.
    PubMed     Text format     Abstract available
    
    
19. PARK S, Reuter VE, Hansel DE
    Non-urothelial carcinomas of the bladder.
    Histopathology. 2019;74:97-111.
    PubMed     Text format     Abstract available
    
    

    
    In Vivo

20. IZUMI K, Iwamoto H, Yaegashi H, Shigehara K, et al
    Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.
    In Vivo. 2019;33:167-172.
    PubMed     Text format     Abstract available
    
    

    
    Indian J Cancer

21. PRAKASH G, Pal M, Odaiyappan K, Shinde R, et al
    Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
    Indian J Cancer. 2019;56:54-58.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

22. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

23. LIN JF, Tsai TF, Lin YC, Chen HE, et al
    Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells.
    Int J Oncol. 2019 Mar 26. doi: 10.3892/ijo.2019.4763.
    PubMed     Text format     Abstract available
    
    
24. SUGITA S, Yoshino H, Yonemori M, Miyamoto K, et al
    Tumorsuppressive microRNA223 targets WDR62 directly in bladder cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4762.
    PubMed     Text format     Abstract available
    
    

    
    Int Urol Nephrol

25. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    PubMed     Text format     Abstract available
    
    
26. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    PubMed     Text format     Abstract available
    
    

    
    J BUON

27. KACHRILAS S, Dellis A, Papatsoris A, Avgeris S, et al
    PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancer.
    J BUON. 2019;24:329-337.
    PubMed     Text format     Abstract available
    
    

    
    J Cell Mol Med

28. GAO H, Yu G, Zhang X, Yu S, et al
    BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
    J Cell Mol Med. 2019 Apr 1. doi: 10.1111/jcmm.14266.
    PubMed     Text format     Abstract available
    
    

    
    J Cell Physiol

29. LIANG T, Wang Y, Wang Y, Wang Y, et al
    Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
    J Cell Physiol. 2019 Apr 2. doi: 10.1002/jcp.28574.
    PubMed     Text format     Abstract available
    
    
30. YAN X, Guo ZX, Liu XP, Feng YJ, et al
    Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    J Cell Physiol. 2019 Mar 29. doi: 10.1002/jcp.28546.
    PubMed     Text format     Abstract available
    
    

    
    J Exp Clin Cancer Res

31. MIAO L, Liu HY, Zhou C, He X, et al
    LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    J Exp Clin Cancer Res. 2019;38:143.
    PubMed     Text format     Abstract available
    
    

    
    J Pathol

32. YU CC, Li CF, Chen IH, Lai MT, et al
    YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.
    J Pathol. 2019 Apr 3. doi: 10.1002/path.5274.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

33. HAMILTON-REEVES JM, Stanley A, Bechtel MD, Yankee TM, et al
    Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
    J Urol. 2018;200:292-301.
    PubMed     Text format     Abstract available
    
    

    
    Korean J Radiol

34. KARAOSMANOGLU AD, Onur MR, Karcaaltincaba M, Akata D, et al
    Secondary Tumors of the Urinary System: An Imaging Conundrum.
    Korean J Radiol. 2018;19:742-751.
    PubMed     Text format     Abstract available
    
    

    
    Mod Pathol

35. TRETIAKOVA M, Fulton R, Kocherginsky M, Long T, et al
    Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.
    Mod Pathol. 2018;31:623-632.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer Ther

36. WANG F, Zhang H, Ma AH, Yu W, et al
    COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.
    Mol Cancer Ther. 2018;17:474-483.
    PubMed     Text format     Abstract available
    
    

    
    Mol Immunol

37. MU XY, Wang RJ, Yao ZX, Zheng Z, et al
    RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
    Mol Immunol. 2019;109:140-148.
    PubMed     Text format     Abstract available
    
    

    
    Mol Ther

38. XIE Q, Chen C, Li H, Xu J, et al
    miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
    Mol Ther. 2019 Mar 15. pii: S1525-0016(19)30092.
    PubMed     Text format     Abstract available
    
    

    
    Oncologist

39. NICOLAZZO C, Busetto GM, Gradilone A, Sperduti I, et al
    Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
    Oncologist. 2019 Apr 3. pii: theoncologist.2018-0784.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Urol

40. NILBERT M, Blackberg M, Ceberg J, Hagberg O, et al
    Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Scand J Urol. 2018;52:237-243.
    PubMed     Text format     Abstract available
    
    

    
    Toxicol Appl Pharmacol

41. ZHU Q, Sheng Y, Li W, Wang J, et al
    Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.
    Toxicol Appl Pharmacol. 2019 Apr 1. pii: S0041-008X(19)30117.
    PubMed     Text format     Abstract available
    
    

    
    World J Urol

42. BOERI L, Montanari E, Karnes RJ
    Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-1542.
    World J Urol. 2019 Apr 3. pii: 10.1007/s00345-019-02751.
    PubMed     Text format    
    
    

    
    Zhonghua Wai Ke Za Zhi

43. HAO YC, Xiao CL, Liu K, Liu YQ, et al
    [Application of narrow-band imaging flexible ureteroscopy in the diagnosis, treatment and follow-up of upper tract urothelial carcinomas].
    Zhonghua Wai Ke Za Zhi. 2018;56:222-226.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: